Riskpilot← Back to searchSign inGet full accessTermino c 8879 AB
ABIn liquidationOrg 5569342339Other human health activities · NACE 8690Est. 20130 employees
Revenue 2023
SEK 0
EBITDA margin
—
+850% vs 2021
Equity ratio
100.0%
Financial strength
Net profit 2023
SEK 7K
+158% vs 2021
| Revenue | SEK 0 | — |
| EBITDA | SEK 15K | +850% |
| Net profit | SEK 7K | +158% |
| Total assets | SEK 127K | -91% |
| Equity | SEK 127K | -88% |
| Employees | 0 | — |
Legal name
Termino c 8879 AB
Org number
5569342339
Legal form
Aktiebolag
NACE code
8690 · Other human health activities
Founded
12 juni 2013
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-06-30
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Aktiebolaget skall bedriva förvaltning av värdepapper samt därmed jämförlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2023 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −339 | −32 | −14 | −2 | 15 |
| Depreciation & amort. | −10 | −10 | −10 | −10 | −8 |
| EBIT | −349 | −42 | −24 | −12 | 7 |
| Net financials | — | — | — | — | — |
| Profit before tax | −349 | 204 | −24 | −12 | 7 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −349 | 204 | −24 | −12 | 7 |
| Item | 2018 | 2019 | 2020 | 2021 | 2023 |
|---|---|---|---|---|---|
| Total assets | 1 515 | 1 498 | 1 488 | 1 470 | 127 |
| Equity | 911 | 1 116 | 1 092 | 1 080 | 127 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 358 | 382 | 397 | 390 | 0 |
| Total debt | 358 | 382 | 397 | 390 | — |
EBITDA margin
1500000.0%
This company
15.8%
Market median
+9493571% vs market
20182023
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20182023
Return on equity
5.5%
This company
18.4%
Market median
-70% vs market
20182023
Net profit margin
700000.0%
This company
8.1%
Market median
+8641875% vs market
20182023
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20182023
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20182023
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-01-01 – 2023-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TN Liquidator | Liquidator | 2020 |
| Name | Role | Member since |
|---|---|---|
| Former (3) | ||
| Deputy Board Member | 2023 – 2023 | |
| Chairman | 2020 – 2021 | |
| Board of Directors | 2020 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
VaccinDirekt Nordic Holding AB
Termino c 8879 AB Board members of Termino c 8879 AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Torbjörn Nordberg | Liquidator | 0 companies |
| Sara Elisabeth Andersson | Deputy Board Member | 0 companies |
| Toni-Pekka Haapanen | Chairman | 0 companies |
| Kenneth Christian Virkkunen | Board of Directors | 0 companies |